Finance

Lists
GUD:TSE
Knight Therapeutics Inc
CA$ 10.71
+1.61%
(+0.17) 1D
10-р сарын 7, 16:00:00 (GMT-4)  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for GUD...
Open
CA$ 10.31
High
CA$ 10.79
Low
CA$ 10.31
Mkt. cap
1.05 тэрбум
Avg. vol.
80.88 мян
Volume
61.37 мян
P/E ratio
71.41
52-wk high
CA$ 10.80
52-wk low
CA$ 5.66
EPS
CA$ 0.15
Beta
-0.07
Shares outstanding
98.23 сая
No. of employees
830
Open
CA$ 10.31
High
CA$ 10.79
Low
CA$ 10.31
Mkt. cap
1.05 тэрбум
Avg. vol.
80.88 мян
Volume
61.37 мян
P/E ratio
71.41
52-wk high
CA$ 10.80
52-wk low
CA$ 5.66
EPS
CA$ 0.15
Beta
-0.07
Shares outstanding
98.23 сая
No. of employees
830
News stories
From web sources and news partners
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersМонреал, Кэбэк, Канад
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 6
Fiscal period
Q2 2026
-CA$ 0.03 /
0.00%miss
Revenue / Est. (CAD)
144.21 сая / 128.90 сая
+11.88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
121.55 сая
133.11 сая
148.44 сая
144.21 сая
Cost of goods sold
65.74 сая
68.38 сая
79.33 сая
74.60 сая
Cost of revenue
65.74 сая
68.38 сая
79.33 сая
74.60 сая
Research and development expenses
8.69 сая
9.22 сая
9.41 сая
10.56 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.02 сая
35.45 сая
34.45 сая
36.64 сая
Operating expense
55.16 сая
58.51 сая
58.53 сая
60.66 сая
Total operating expenses
120.90 сая
126.90 сая
137.86 сая
135.25 сая
Operating income
646.00 мян
6.21 сая
10.58 сая
8.96 сая
Other non operating income
-271.00 мян
329.00 мян
4.17 сая
-487.00 мян
EBT including unusual items
-1.92 сая
11.22 сая
14.18 сая
-2.10 сая
EBT excluding unusual items
2.24 сая
1.57 сая
15.50 сая
7.21 сая
Income tax expense
1.87 сая
2.37 сая
1.01 сая
1.26 сая
Effective tax rate
-97.76%
21.12%
7.14%
-59.82%
Other operating expenses
-
-
-
-
Net income
-3.79 сая
8.85 сая
13.17 сая
-3.36 сая
Net profit margin
-3.12%
6.65%
8.87%
-2.33%
Earnings per share
-0.02
0.10
0.14
-0.03
Interest and investment income
1.11 сая
1.22 сая
952.00 мян
901.00 мян
Interest expense
-2.37 сая
-3.92 сая
-2.64 сая
-2.12 сая
Net interest expenses
-1.26 сая
-2.70 сая
-1.69 сая
-1.22 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
18.41 сая
16.47 сая
26.77 сая
23.97 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс